期刊
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
卷 16, 期 7, 页码 807-821出版社
HARBORSIDE PRESS
DOI: 10.6004/jnccn.2018.0062
关键词
-
类别
资金
- Golden Biotech, Inc.
- AbbVie Inc.
- Bristol-Myers Squibb Company
The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the targeted therapy and immunotherapy sections in the NCCN Guidelines. For the 2018 update, a new section on biomarkers was added.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据